Annual Cash & Cash Equivalents
$762.00M$568.00M+292.78%
Summary
- Current Value
- As of today, SOLV annual cash & cash equivalents is $762.00M, up +292.78% on
- Historical Performance
- SOLV annual cash & cash equivalents is up +737.36% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- SOLV annual cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- SOLV annual cash & cash equivalents is +1149.18% above its 3-year low of $61.00M reached on an earlier date
- Sector Comparison
- SOLV annual cash & cash equivalents is higher than 91.86% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $762.00M | +292.8% | +737.4% | – | – | |
| Quarterly Cash & Cash Equivalents | $1.64B | +112.7% | – | – | – | |
| Price | $86.14 | +24.9% | – | – | – | |
| Annual Current Assets | $3.25B | +29.0% | +48.4% | – | – | |
| Annual Total Liabilities | $11.50B | +405.0% | +470.3% | – | – | |
| Annual Working Capital | $546.00M | -31.0% | -30.3% | – | – | |
| Annual Net Income | $479.00M | -64.4% | -67.2% | -57.9% | -57.9% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $762.00M | at high | |
| 5Y | $762.00M | at high | |
| All | $762.00M | at high |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $61.00M | N/A | +1149.2% |
| 5Y | $61.00M | +1149.2% | |
| All | $61.00M | +1149.2% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $762.00M | +292.8% | |
| $194.00M | +218.0% |
| Year | Value | Change |
|---|---|---|
| $61.00M | -33.0% | |
| $91.00M | - |
FAQ
What is the current annual cash & cash equivalents of SOLV?
As of today, SOLV annual cash & cash equivalents is $762.00M
What is 1-year change in SOLV annual cash & cash equivalents?
SOLV annual cash & cash equivalents is up +292.78% year-over-year
What is 3-year change in SOLV annual cash & cash equivalents?
SOLV annual cash & cash equivalents is up +737.36% over the past 3 years
How far is SOLV annual cash & cash equivalents from its all-time high?
SOLV annual cash & cash equivalents is currently at its all-time high
How does SOLV annual cash & cash equivalents rank versus sector peers?
SOLV annual cash & cash equivalents is higher than 91.86% of companies in Healthcare sector
When is SOLV next annual earnings release?
The next annual earnings release for SOLV is on
Quarterly Cash & Cash Equivalents
$1.64B$1.15B+233.74%
Summary
- Current Value
- As of today, SOLV quarterly cash & cash equivalents is $1.64B, up +233.74% on
- Historical Performance
- SOLV quarterly cash & cash equivalents is up +112.69% year-over-year, with unknown 3-year change
- All-Time High Comparison
- SOLV quarterly cash & cash equivalents is currently at its all-time high
- 3-Year Low Comparison
- SOLV quarterly cash & cash equivalents is +2591.80% above its 3-year low of $61.00M reached on an earlier date
- Sector Comparison
- SOLV quarterly cash & cash equivalents is higher than 94.71% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.64B | +233.7% | +112.7% | – | – | |
| Annual Cash & Cash Equivalents | $762.00M | – | +292.8% | +737.4% | – | |
| Price | $86.14 | +20.0% | +24.9% | – | – | |
| Quarterly Current Assets | $4.41B | +37.4% | +31.4% | – | – | |
| Quarterly Total Liabilities | $8.99B | -21.4% | -22.2% | – | – | |
| Quarterly Working Capital | $1.47B | +149.8% | +226.4% | – | – | |
| Quarterly Net Income | $1.27B | +1306.7% | +937.7% | +277.9% | +277.9% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.64B | at high | |
| 3Y | $1.64B | at high | |
| 5Y | $1.64B | at high | |
| All | $1.64B | at high |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $492.00M | +233.7% | |
| 3Y | $61.00M | N/A | +2591.8% |
| 5Y | $61.00M | +2591.8% | |
| All | $61.00M | +2591.8% |
Quarterly Cash & Cash Equivalents History
| Month | Value | Change |
|---|---|---|
| $1.64B | +233.7% | |
| $492.00M | -7.9% | |
| $534.00M | -29.9% | |
| $762.00M | -1.3% | |
| $772.00M | -13.9% |
| Month | Value | Change |
|---|---|---|
| $897.00M | -9.9% | |
| $996.00M | +413.4% | |
| $194.00M | -61.2% | |
| $500.00M | 0.0% | |
| $500.00M | - |
FAQ
What is the current quarterly cash & cash equivalents of SOLV?
As of today, SOLV quarterly cash & cash equivalents is $1.64B
What is SOLV quarterly cash & cash equivalents most recent change?
SOLV quarterly cash & cash equivalents was up +233.74% on September 30, 2025
What is 1-year change in SOLV quarterly cash & cash equivalents?
SOLV quarterly cash & cash equivalents is up +112.69% year-over-year
How far is SOLV quarterly cash & cash equivalents from its all-time high?
SOLV quarterly cash & cash equivalents is currently at its all-time high
How does SOLV quarterly cash & cash equivalents rank versus sector peers?
SOLV quarterly cash & cash equivalents is higher than 94.71% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1964738/000196473825000091/0001964738-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473825000019/0001964738-25-000019-index.htm
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv